Screening and Evaluation of Human Intestinal Lactobacilli for the Development of Novel Gastrointestinal Probiotics

被引:39
作者
Koll, Piret [1 ]
Maendar, Reet [1 ]
Smidt, Imbi [1 ]
Huett, Pirje [1 ]
Truusalu, Kai [1 ]
Mikelsaar, Raik-Hiio [1 ]
Shchepetova, Jelena [1 ]
Krogh-Andersen, Kasper [2 ]
Marcotte, Harold [2 ]
Hammarstrom, Lennart [2 ]
Mikelsaar, Marika [1 ]
机构
[1] Univ Tartu, Dept Microbiol, EE-50090 Tartu, Estonia
[2] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Clin Immunol, Dept Lab Med, Stockholm, Sweden
关键词
RESISTANCE DETERMINANT; ORAL LACTOBACILLI; CHAIN ANTIBODY; SAFETY; SUSCEPTIBILITY; FRAGMENTS; BACTERIA; DELIVERY; STRAINS; SPP;
D O I
10.1007/s00284-010-9653-y
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The aim of this study was to screen intestinal lactobacilli strains for their advantageous properties to select those that could be used for the development of novel gastrointestinal probiotics. Ninety-three isolates were subjected to screening procedures. Fifty-nine percent of the examined lactobacilli showed the ability to auto-aggregate, 97% tolerated a high concentration of bile (2% w/v), 50% survived for 4 h at pH 3.0, and all strains were unaffected by a high concentration of pancreatin (0.5% w/v). One Lactobacillus buchneri strain was resistant to tetracycline. None of the tested strains caused lysis of human erythrocytes. Six potential probiotic strains were selected for safety evaluation in a mouse model. Five of 6 strains caused no translocation, and were considered safe. In conclusion, several strains belonging to different species and fermentation groups were found that have properties required for a potential probiotic strain. This study was the first phase of a multi-phase study aimed to develop a novel, safe and efficient prophylactic and therapeutic treatment system against gastrointestinal infections using genetically modified probiotic lactobacilli.
引用
收藏
页码:560 / 566
页数:7
相关论文
共 34 条
[1]   Characterization of intestinal lactobacilli as putative probiotic candidates [J].
Annuk, H ;
Shchepetova, J ;
Kullisaar, T ;
Songisepp, E ;
Zilmer, M ;
Mikelsaar, M .
JOURNAL OF APPLIED MICROBIOLOGY, 2003, 94 (03) :403-412
[2]  
[Anonymous], 2006, FOOD NUTR PAPER
[3]   IDENTIFICATION AND CLONING OF A PLASMID-ENCODED ERYTHROMYCIN RESISTANCE DETERMINANT FROM LACTOBACILLUS-REUTERI [J].
AXELSSON, LT ;
AHRNE, SEI ;
ANDERSSON, MC ;
STAHL, SR .
PLASMID, 1988, 20 (02) :171-174
[4]   Adhesion and aggregation properties of probiotic and pathogen strains [J].
Collado, Maria Carmen ;
Meriluoto, Jussi ;
Salminen, Seppo .
EUROPEAN FOOD RESEARCH AND TECHNOLOGY, 2008, 226 (05) :1065-1073
[5]  
Cotran RS., 1999, PATHOLOGIC BASIS DIS, V5th
[6]   Susceptibility of Lactobacillus spp. to antimicrobial agents [J].
Danielsen, M ;
Wind, A .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2003, 82 (01) :1-11
[7]   Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract [J].
Delgado, S ;
Flórez, AB ;
Mayo, B .
CURRENT MICROBIOLOGY, 2005, 50 (04) :202-207
[8]  
Gardiner G, 1998, APPL ENVIRON MICROB, V64, P2192
[9]   In vitro conjugal transfer of tetracycline resistance from Lactobacillus isolates to other Gram-positive bacteria [J].
Gevers, D ;
Huys, G ;
Swings, J .
FEMS MICROBIOLOGY LETTERS, 2003, 225 (01) :125-130
[10]  
Hayford AE, 1999, APPL ENVIRON MICROB, V65, P3213